Reporting owner · CIK 0002124509
Mancini Anthony
SEC Form 4 history across 1 companies, 15 transactions and 5 filings.
SRSee RemarksRevolution Medicines, Inc.
Open-market transaction mix0% buys0 buys · 9 sales
Available history · May 26, 2026 – Oct 26, 2026
Latest insider transactions
Form 4 filings from available history.| Company | Insider | Activity | Disclosed value | Filed (ET) |
|---|---|---|---|---|
RVMDRevolution Medicines, Inc. | Mancini AnthonySR | M · exercise10b5-1 detectedDerivative securitySEC filing ↗ | $0View disclosure → | |
RVMDRevolution Medicines, Inc. | Mancini AnthonySR | S · sale10b5-1 detectedSEC filing ↗ | -$431kView disclosure → | |
RVMDRevolution Medicines, Inc. | Mancini AnthonySR | M · exercise10b5-1 detectedSEC filing ↗ | $77.6kView disclosure → | |
RVMDRevolution Medicines, Inc. | Mancini AnthonySR | M · exercise10b5-1 detectedDerivative securitySEC filing ↗ | $0View disclosure → | |
RVMDRevolution Medicines, Inc. | Mancini AnthonySR | S · sale10b5-1 detectedSEC filing ↗ | -$625kView disclosure → | |
RVMDRevolution Medicines, Inc. | Mancini AnthonySR | M · exercise10b5-1 detectedSEC filing ↗ | $104kView disclosure → | |
RVMDRevolution Medicines, Inc. | Mancini AnthonySR | S · sale10b5-1 detectedSEC filing ↗ | -$117kView disclosure → | |
RVMDRevolution Medicines, Inc. | Mancini AnthonySR | S · sale10b5-1 detectedSEC filing ↗ | -$347kView disclosure → | |
RVMDRevolution Medicines, Inc. | Mancini AnthonySR | S · sale10b5-1 detectedSEC filing ↗ | -$348kView disclosure → | |
RVMDRevolution Medicines, Inc. | Mancini AnthonySR | S · sale10b5-1 detectedSEC filing ↗ | -$5.26kView disclosure → | |
RVMDRevolution Medicines, Inc. | Mancini AnthonySR | M · exercise10b5-1 detectedDerivative securitySEC filing ↗ | $0View disclosure → | |
RVMDRevolution Medicines, Inc. | Mancini AnthonySR | S · sale10b5-1 detectedSEC filing ↗ | -$65.1kView disclosure → | |
RVMDRevolution Medicines, Inc. | Mancini AnthonySR | S · sale10b5-1 detectedSEC filing ↗ | -$308kView disclosure → | |
RVMDRevolution Medicines, Inc. | Mancini AnthonySR | S · sale10b5-1 detectedSEC filing ↗ | -$107kView disclosure → | |
RVMDRevolution Medicines, Inc. | Mancini AnthonySR | M · exercise10b5-1 detectedSEC filing ↗ | $104kView disclosure → |
Latest Form 4 facts
Quick context from source filings
Latest open-market transaction
sale at Revolution Medicines, Inc. on Oct 26, 2026 valued at $431,947.
Review SEC filingLatest buy
No open-market insider purchase is available.
Monthly open-market activity
Last 3 reported months · purchases and sales
View exact monthly values
| Month | Purchases | Sales | Buy value | Sale value | Net value |
|---|---|---|---|---|---|
| May 2026 | 0 | 3 | $0.00 | $480,610.82 | -$480,610.82 |
| Sep 2026 | 0 | 5 | $0.00 | $1,444,136.60 | -$1,444,136.60 |
| Oct 2026 | 0 | 1 | $0.00 | $431,946.90 | -$431,946.90 |
Net value is disclosed purchases minus sales, not profit. A dash means the value is unavailable.
Ownership and transaction size
Ownership and ticket size
Average P/S size$261.9K
Median P/S size$308.1K
Direct15
Indirect0
Oct 26, 2026exercise
Filing-only signals
Deterministic matches in this insider's history
Associated companies
Companies in the disclosed reporting history
Open-market buy performance
90-day forward return on this insider's open-market purchases
No open-market purchases in available history
A 90-day purchase return requires an open-market buy. No eligible purchases are recorded in this history.
Disclosed ownership
How reported shareholdings evolved
Non-derivative shares held after reported transactions—not stock prices or a complete portfolio.
12 observations · May 26, 2026 – Oct 26, 2026. Window ends at the latest available report, not today.
Selected observation · Oct 26, 202639,765 shares reported
Inspect transaction View exact observations and source transactions
| Transaction date | Shares held after | Filed | Source |
|---|---|---|---|
| May 26, 2026 | 57,521 | May 28, 2026 | View transaction |
| May 26, 2026 | 56,821 | May 28, 2026 | View transaction |
| May 26, 2026 | 54,821 | May 28, 2026 | View transaction |
| May 26, 2026 | 54,400 | May 28, 2026 | View transaction |
| Sep 16, 2026 | 43,863 | Sep 18, 2026 | View transaction |
| Sep 16, 2026 | 42,116 | Sep 18, 2026 | View transaction |
| Sep 18, 2026 | 40,352 | Sep 22, 2026 | View transaction |
| Sep 24, 2026 | 39,765 | Sep 28, 2026 | View transaction |
| Sep 25, 2026 | 42,886 | Sep 28, 2026 | View transaction |
| Sep 25, 2026 | 39,765 | Sep 28, 2026 | View transaction |
| Oct 26, 2026 | 42,075 | Oct 28, 2026 | View transaction |
| Oct 26, 2026 | 39,765 | Oct 28, 2026 | View transaction |
Securities and direct/indirect ownership contexts are kept separate and never summed. Joint filings may associate the same disclosed row with multiple owners. Unknown values are omitted, not treated as zero. Lines connect observations for readability; they do not establish holdings between filings, cost basis, or current ownership. Amendments and stock splits require reviewing the source.
Mancini Anthony Insider Activity FAQ
SEC Form 4 context
Who is Mancini Anthony?
Mancini Anthony is a reporting owner in SEC Form 4 filings with reporting owner CIK 0002124509.
Which companies has Mancini Anthony reported transactions for?
Revolution Medicines, Inc.
When was Mancini Anthony's latest insider buy?
No open-market insider purchase is available for this period.
When was Mancini Anthony's latest insider sale?
sale at Revolution Medicines, Inc. on Oct 26, 2026 valued at $431,947.
Where can I see the original SEC filings?
Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.
Are performance metrics included?
The profile shows average and median 90-day stock returns after open-market purchases when price coverage is available. These are unadjusted stock returns, not realized trading gains. Win rates, benchmark-adjusted returns and conviction scores are not calculated.